Analyzing Konica Minolta (OTCMKTS:KNCAY) & Infleqtion (NYSE:INFQ)

Infleqtion (NYSE:INFQ) and Konica Minolta (OTCMKTS:KNCAY) are both technology companies, but which is the superior business? We will contrast the two companies based on the strength of their earnings, risk, analyst recommendations, dividends, institutional ownership, valuation and profitability.

Valuation & Earnings

This table compares Infleqtion and Konica Minolta”s gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Infleqtion	N/A	N/A	-$66.93 million	($0.09)	-141.77
Konica Minolta	$7.23 billion	0.26	$199.77 million	($0.05)	-153.00

Konica Minolta has higher revenue and earnings than Infleqtion. Konica Minolta is trading at a lower price-to-earnings ratio than Infleqtion, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares Infleqtion and Konica Minolta’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Infleqtion	N/A	-60.34%	-15.09%
Konica Minolta	N/A	N/A	N/A

Analyst Ratings

This is a breakdown of recent recommendations for Infleqtion and Konica Minolta, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Infleqtion	1	1	5	1	2.75
Konica Minolta	0	0	0	0	0.00

Infleqtion currently has a consensus target price of $20.60, indicating a potential upside of 61.45%. Given Infleqtion’s stronger consensus rating and higher possible upside, equities analysts plainly believe Infleqtion is more favorable than Konica Minolta.

About Infleqtion

We are a blank check company incorporated as a Cayman Islands exempted company and formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses, which we refer to throughout this prospectus as our initial business combination. We have not selected any business combination target and we have not, nor has anyone on our behalf, initiated any substantive discussions, directly or indirectly, with any business combination target. We may pursue an initial business combination in any business or industry but expect to focus on a target in an industry where we believe our management team and founder’s expertise will provide us with a competitive advantage. Our founder, Michael Klein, is also the founder and managing partner of M. Klein and Company, which he founded in 2012. M. Klein and Company is a global strategic advisory firm that provides its clients a variety of advice tailored to their objectives. Mr. Klein is a strategic advisor to global companies, boards of directors, senior executives, governments, and institutional investors. Mr. Klein’s background in strategic advisory work was built during his 35-year career, including more than two decades at Citi and its predecessors, during which he initiated and executed strategic advisory transactions. He began his career as an investment banker in the M&A Advisory Group at Salomon Brothers and subsequently became Chairman and Co-Chief Executive Officer of Citi Markets and Banking, with responsibilities for Global Corporate and Investment Banking and Global Transaction Services across Citi. In his role as Co-Chief Executive Officer, he was responsible for all relationship, advisory, underwriting, and capital markets issuance activity. Our executive offices are located in New York, NY.

About Konica Minolta

Konica Minolta, Inc. engages in digital workplace, professional print, healthcare, and industrial businesses in Japan, China, other Asian countries, the United States, Europe, and internationally. It develops, manufactures, and sells multi-functional peripherals, digital printing systems, and related consumables, as well as offers IT and printing solutions and services. The company also provides diagnostic imaging systems, such as digital X-ray diagnostic imaging, diagnostic ultrasound systems, and other systems; digitalization, networking, solutions, and services in the medical field; genetic testing and drug discovery support services; and primary care services. In addition, it offers measuring instruments; functional film displays; organic light emitting diode lighting products; industrial inkjet printheads; lenses for industrial and professional use; and imaging IoT and visual solutions. The company was founded in 1873 and is headquartered in Tokyo, Japan.